- Home
- CCBG vs ARCT Comparison
CCBG vs ARCT Comparison
Compare CCBG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCBG | ARCT |
|---|---|---|
| Founded | 1895 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.2M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CCBG | ARCT |
|---|---|---|
| Price | $43.69 | $6.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $45.00 | $38.67 |
| AVG Volume (30 Days) | 62.5K | ★ 794.2K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | ★ 17.47 | N/A |
| EPS | ★ 3.57 | N/A |
| Revenue | ★ $246,433,000.00 | $97,601,000.00 |
| Revenue This Year | $12.46 | N/A |
| Revenue Next Year | $3.24 | N/A |
| P/E Ratio | $12.63 | ★ N/A |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $32.38 | $5.85 |
| 52 Week High | $45.63 | $24.17 |
Technical Indicators
Market Signals| Indicator | CCBG | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 35.49 |
| Support Level | $43.18 | $6.38 |
| Resistance Level | $45.48 | $7.76 |
| Average True Range (ATR) | 1.15 | 0.43 |
| MACD | 0.13 | 0.20 |
| Stochastic Oscillator | 70.55 | 24.87 |
Price Performance
Historical ComparisonAbout CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.